For healthcare professionals. This information does not replace clinical judgement in the individual case; the current summary of product characteristics and the guidelines cited are authoritative.
Medically reviewed: Dr. med. univ. Daniel Pehböck, DESA, 01.11.2026
Flumazenil (Benzodiazepine antagonist) – indications: Reversal of benzodiazepine sedation (anaesthesia) – adults, Confirmed or predominantly benzodiazepine-induced poisoning (intensive care) – adults, Reversal of benzodiazepine sedation – children > 1 year. Weight-based dosing in mg and ml in the app, with sources.
Indications
- Reversal of benzodiazepine sedation (anaesthesia) – adults
- Confirmed or predominantly benzodiazepine-induced poisoning (intensive care) – adults
- Reversal of benzodiazepine sedation – children > 1 year
Complete in the app
Weight-based doses in mg and ml, preparations, contraindications and notes – in the app, also offline.
Used in
Sources and guidelines
- Summaries of product characteristics of authorised products – product and section for each dose in the app.